Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 5, 2025Neuro-OncologyOpen Access

P03.16.a MGMT Promoter Methylation Prediction in High Grade Gliomas Using Conventional Mri and Machine Learning Segmentations

View Full Paper
Ask AI
Bookmark
Share

Authors

EZet al. Emina ZahirovicTSTim SalomonssonMKMalte Knutsson

Discussion

Loading...

Member takes

Overview

Analysis reveals that machine learning segmentation improves predictions of MGMTpm status in gliomas, suggesting MRI may enhance management decisions.

Key Points

  • ML models like Raidionics show promise in predicting mgmt promoter methylation using MRI imaging traits.
  • Patients with MGMTpm tumors had lower tumor/edema ratios (0.24) compared to unmethylated ones (0.44), indicating potential imaging biomarkers.
  • Volumetric data was analyzed using manual and machine learning segmentation methods to identify differences in mgmt status.
  • Findings highlight the necessity for future studies to explore different ML models and MRI sequences for better MGMT status differentiation.

Cite This Study

Zahirovic et al. (2025) studied this question.

synapsesocial.com/papers/68e24e59d6d66a53c2472ec6https://doi.org/10.1093/neuonc/noaf193.175
View Full Paper
Ask AI
Bookmark
Share